10x Genomics Inc (TXG) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


10x Genomics Inc   (NASDAQ: TXG)


10x Genomics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



TXG Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -12.23 %
Seq. Revenue Change 0.57 %
Revenue In Millions $151.04
Gross Profit Margin 74.48 %
Gross Profit Margin Total Ranking # 989
Gross Profit In Millions $112.50
Y / Y Gross Profit Change -10.06 %
Seq. Gross Profit Change 5.95 %


Commenting Second Quarter 2026 Gross Profit Margin
10x Genomics Inc Gross Profit grew by 5.95 % in Q2 sequentially to 112 millions, while Revenue increased by 0.57 %, this led to improvement in the company's Gross Profit Margin to 74.48 %, Gross Profit Margin remained below 10x Genomics Inc average.


Observing second quarter 2026 results within Laboratory Analytical Instruments industry 10x Genomics Inc has achieved highest Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 989, from total ranking in the previous quarter at 1159.
Learn about Gross Margin
TXG's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 177
Overall # 981

Gross Profit Margin Statistics
High Average Low
95.76 % 75.13 % 62.22 %
(Jun 30 2021)   (Sep 30 2023)




Other Gross Profit Margin Profitability Ratios
TXG's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
TXG's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for TXG's Competitors
Gross Profit Margin Profit Margin for 10x Genomics Inc 's Suppliers
Gross Profit Margin Profit Margin for TXG's Customers

You may also want to know
TXG's Annual Growth Rates TXG's Profitability Ratios TXG's Asset Turnover Ratio TXG's Dividend Growth
TXG's Roe TXG's Valuation Ratios TXG's Financial Strength Ratios TXG's Gross Profit Growth
TXG's Roa TXG's Inventory Turnover Ratio TXG's Growth Rates TXG's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Nautilus Biotechnology Inc   92.11 %$ 0.175  Millions$ 0.190  Millions
10x Genomics Inc   74.48 %$ 112.497  Millions$ 151.036  Millions
Illumina Inc   66.44 %$ 770.000  Millions$ 1,159.000  Millions
Mettler toledo International Inc   63.29 %$ 650.218  Millions$ 1,027.314  Millions
Alamar Biosciences Inc   60.21 %$ 17.718  Millions$ 29.427  Millions
Cytek Biosciences Inc   58.87 %$ 28.340  Millions$ 48.140  Millions
Revvity Inc  57.13 %$ 416.866  Millions$ 729.688  Millions
Harvard Bioscience Inc   55.57 %$ 12.630  Millions$ 22.727  Millions
Agilent Technologies inc   55.48 %$ 1,042.000  Millions$ 1,878.000  Millions
Bio rad Laboratories Inc   53.12 %$ 345.800  Millions$ 651.000  Millions
Bionano Genomics Inc   52.80 %$ 4.314  Millions$ 8.171  Millions
Standard Biotools Inc   52.40 %$ 10.535  Millions$ 20.104  Millions
Bruker Corporation  49.61 %$ 416.000  Millions$ 838.500  Millions
Seer Inc   48.55 %$ 1.506  Millions$ 3.102  Millions
Lifeloc Technologies Inc   44.68 %$ 1.093  Millions$ 2.445  Millions
Precipio inc   44.67 %$ 3.136  Millions$ 7.021  Millions
Waters Corporation  44.62 %$ 734.000  Millions$ 1,645.000  Millions
Scientific Industries Inc   42.35 %$ 0.623  Millions$ 1.470  Millions
Quanterix Corporation  38.52 %$ 12.674  Millions$ 32.906  Millions
Pacific Biosciences Of California Inc   32.40 %$ 12.638  Millions$ 39.007  Millions
Kewaunee Scientific Corporation  29.61 %$ 19.639  Millions$ 66.320  Millions
Rapid Micro Biosystems Inc   15.05 %$ 1.212  Millions$ 8.054  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.